Related references
Note: Only part of the references are listed.Polystyrene microplastic particles induce autophagic cell death in BEAS-2B human bronchial epithelial cells
Mi Seon Jeon et al.
ENVIRONMENTAL TOXICOLOGY (2023)
Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib
Zhifei Xu et al.
AUTOPHAGY (2022)
PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1)
Peihua Luo et al.
AUTOPHAGY (2021)
The effect of metformin in EML4-ALK+ lung cancer alone and in combination with crizotinib in cell and rodent models
A. R. Bland et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Bisdemethoxycurcumin alleviates vandetanib-induced cutaneous toxicity in vivo and in vitro through autophagy activation
Ying Jin et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Crizotinib in Patients With MET-Amplified NSCLC
D. Ross Camidge et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib
Jiangxia Du et al.
TOXICOLOGY LETTERS (2021)
Construction of a human cell landscape at single-cell level
Xiaoping Han et al.
NATURE (2020)
Macrophage M1/M2 polarization
Chen Yunna et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
BCAT1 binds the RNA-binding protein ZNF423 to activate autophagy via the IRE1-XBP-1-RIDD axis in hypoxic PASMCs
Wei Xin et al.
CELL DEATH & DISEASE (2020)
Autophagy markers as mediators of lung injury-implication for therapeutic intervention
Selvaraj Vishnupriya et al.
LIFE SCIENCES (2020)
Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing
Hidenori Mizugaki et al.
LUNG CANCER (2019)
Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis
Guanqun Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Interstitial Lung Disease Onset and Its Risk Factors in Japanese Patients With ALK-Positive NSCLC After Treatment With Crizotinib
Akihiko Gemma et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Pharmacology of metformin - An update
Hartmut H. Glossmann et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome
Joshua A. Englert et al.
JCI INSIGHT (2019)
Lung cancer and interstitial lung disease: a literature review
Jean-Marc Naccache et al.
JOURNAL OF THORACIC DISEASE (2018)
AMPK contributes to autophagosome maturation and lysosomal fusion
Minsu Jang et al.
SCIENTIFIC REPORTS (2018)
Metformin suppresses CRC growth by inducing apoptosis via ADORA1
Bin Lan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2017)
Autophagy in Pulmonary Diseases
Kiichi Nakahira et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Clinical Implications of the Pharmacokinetics of Crizotinib in Populations of Patients with Non-Small Cell Lung Cancer
Erjian Wang et al.
CLINICAL CANCER RESEARCH (2016)
The Essential Role of Neutrophils during Infection with the Intracellular Bacterial Pathogen Listeria monocytogenes
Alexandra R. Witter et al.
JOURNAL OF IMMUNOLOGY (2016)
Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway
Li Li et al.
ONCOTARGET (2016)
Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis
Sandra Cabrera et al.
AUTOPHAGY (2015)
Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease A Retrospective Observational Cohort Study with a Systematic Literature Review
Perrine Crequit et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell
Gang Han et al.
CANCER BIOLOGY & THERAPY (2015)
CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile
Elena Sierra-Filardi et al.
JOURNAL OF IMMUNOLOGY (2014)
Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion
Jing Zhou et al.
CELL RESEARCH (2013)
Crizotinib in the Treatment of Non-Small-Cell Lung Cancer
Sacha I. Rothschild et al.
CLINICAL LUNG CANCER (2013)
Impairment of autophagy: From hereditary disorder to drug intoxication
Toshihiko Aki et al.
TOXICOLOGY (2013)
Consensus statement for the diagnosis and treatment of drug-induced lung injuries
Keishi Kubo et al.
RESPIRATORY INVESTIGATION (2013)
Lung Cancer: New Biological Insights and Recent Therapeutic Advances
Suresh S. Ramalingam et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight
Ji Hye Min et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Targeting Anaplastic Lymphoma Kinase in Lung Cancer
Alice T. Shaw et al.
CLINICAL CANCER RESEARCH (2011)
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
Issam Ben Sahra et al.
CANCER RESEARCH (2010)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
An orally available small-molecule inhibitor of c-met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms
Helen Y. Zou et al.
CANCER RESEARCH (2007)
Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin
WE Lawson et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)